Eintrag weiter verarbeiten
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.
Gespeichert in:
| Zeitschriftentitel: | Proceedings of the National Academy of Sciences |
|---|---|
| Personen und Körperschaften: | , , , , , , |
| In: | Proceedings of the National Academy of Sciences, 92, 1995, 20, S. 9288-9292 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Proceedings of the National Academy of Sciences
|
| Schlagwörter: |
| author_facet |
Delude, R L Savedra, R Zhao, H Thieringer, R Yamamoto, S Fenton, M J Golenbock, D T Delude, R L Savedra, R Zhao, H Thieringer, R Yamamoto, S Fenton, M J Golenbock, D T |
|---|---|
| author |
Delude, R L Savedra, R Zhao, H Thieringer, R Yamamoto, S Fenton, M J Golenbock, D T |
| spellingShingle |
Delude, R L Savedra, R Zhao, H Thieringer, R Yamamoto, S Fenton, M J Golenbock, D T Proceedings of the National Academy of Sciences CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Multidisciplinary |
| author_sort |
delude, r l |
| spelling |
Delude, R L Savedra, R Zhao, H Thieringer, R Yamamoto, S Fenton, M J Golenbock, D T 0027-8424 1091-6490 Proceedings of the National Academy of Sciences Multidisciplinary http://dx.doi.org/10.1073/pnas.92.20.9288 <jats:p>Binding of the lipid A portion of bacterial lipopolysaccharide (LPS) to leukocyte CD14 activates phagocytes and initiates the septic shock syndrome. Two lipid A analogs, lipid IVA and Rhodobacter sphaeroides lipid A (RSLA), have been described as LPS-receptor antagonists when tested with human phagocytes. In contrast, lipid IVA activated murine phagocytes, whereas RSLA was an LPS antagonist. Thus, these compounds displayed a species-specific pharmacology. To determine whether the species specificity of these LPS antagonists occurred as a result of interactions with CD14, the effects of lipid IVA and RSLA were examined by using human, mouse, and hamster cell lines transfected with murine or human CD14 cDNA expression vectors. These transfectants displayed sensitivities to lipid IVA and RSLA that reflected the sensitivities of macrophages of similar genotype (species) and were independent of the source of CD14 cDNA. For example, hamster macrophages and hamster fibroblasts transfected with either mouse or human-derived CD14 cDNA responded to lipid IVA and RSLA as LPS mimetics. Similarly, lipid IVA and RSLA acted as LPS antagonists in human phagocytes and human fibrosarcoma cells transfected with either mouse or human-derived CD14 cDNA. Therefore, the target of these LPS antagonists, which is encoded in the genomes of these cells, is distinct from CD14. Although the expression of CD14 is required for macrophage-like sensitivity to LPS, CD14 cannot discriminate between the lipid A moieties of these agents. We hypothesize that the target of the LPS antagonists is a lipid A recognition protein which functions as a signaling receptor that is triggered after interaction with CD14-bound LPS.</jats:p> CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proceedings of the National Academy of Sciences |
| doi_str_mv |
10.1073/pnas.92.20.9288 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjkyLjIwLjkyODg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjkyLjIwLjkyODg |
| institution |
DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 |
| imprint |
Proceedings of the National Academy of Sciences, 1995 |
| imprint_str_mv |
Proceedings of the National Academy of Sciences, 1995 |
| issn |
0027-8424 1091-6490 |
| issn_str_mv |
0027-8424 1091-6490 |
| language |
English |
| mega_collection |
Proceedings of the National Academy of Sciences (CrossRef) |
| match_str |
delude1995cd14enhancescellularresponsestoendotoxinwithoutimpartingligandspecificrecognition |
| publishDateSort |
1995 |
| publisher |
Proceedings of the National Academy of Sciences |
| recordtype |
ai |
| record_format |
ai |
| series |
Proceedings of the National Academy of Sciences |
| source_id |
49 |
| title |
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_unstemmed |
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_full |
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_fullStr |
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_full_unstemmed |
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_short |
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_sort |
cd14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| topic |
Multidisciplinary |
| url |
http://dx.doi.org/10.1073/pnas.92.20.9288 |
| publishDate |
1995 |
| physical |
9288-9292 |
| description |
<jats:p>Binding of the lipid A portion of bacterial lipopolysaccharide (LPS) to leukocyte CD14 activates phagocytes and initiates the septic shock syndrome. Two lipid A analogs, lipid IVA and Rhodobacter sphaeroides lipid A (RSLA), have been described as LPS-receptor antagonists when tested with human phagocytes. In contrast, lipid IVA activated murine phagocytes, whereas RSLA was an LPS antagonist. Thus, these compounds displayed a species-specific pharmacology. To determine whether the species specificity of these LPS antagonists occurred as a result of interactions with CD14, the effects of lipid IVA and RSLA were examined by using human, mouse, and hamster cell lines transfected with murine or human CD14 cDNA expression vectors. These transfectants displayed sensitivities to lipid IVA and RSLA that reflected the sensitivities of macrophages of similar genotype (species) and were independent of the source of CD14 cDNA. For example, hamster macrophages and hamster fibroblasts transfected with either mouse or human-derived CD14 cDNA responded to lipid IVA and RSLA as LPS mimetics. Similarly, lipid IVA and RSLA acted as LPS antagonists in human phagocytes and human fibrosarcoma cells transfected with either mouse or human-derived CD14 cDNA. Therefore, the target of these LPS antagonists, which is encoded in the genomes of these cells, is distinct from CD14. Although the expression of CD14 is required for macrophage-like sensitivity to LPS, CD14 cannot discriminate between the lipid A moieties of these agents. We hypothesize that the target of the LPS antagonists is a lipid A recognition protein which functions as a signaling receptor that is triggered after interaction with CD14-bound LPS.</jats:p> |
| container_issue |
20 |
| container_start_page |
9288 |
| container_title |
Proceedings of the National Academy of Sciences |
| container_volume |
92 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792343410321915912 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:51:15.109Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=CD14+enhances+cellular+responses+to+endotoxin+without+imparting+ligand-specific+recognition.&rft.date=1995-09-26&genre=article&issn=1091-6490&volume=92&issue=20&spage=9288&epage=9292&pages=9288-9292&jtitle=Proceedings+of+the+National+Academy+of+Sciences&atitle=CD14+enhances+cellular+responses+to+endotoxin+without+imparting+ligand-specific+recognition.&aulast=Golenbock&aufirst=D+T&rft_id=info%3Adoi%2F10.1073%2Fpnas.92.20.9288&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792343410321915912 |
| author | Delude, R L, Savedra, R, Zhao, H, Thieringer, R, Yamamoto, S, Fenton, M J, Golenbock, D T |
| author_facet | Delude, R L, Savedra, R, Zhao, H, Thieringer, R, Yamamoto, S, Fenton, M J, Golenbock, D T, Delude, R L, Savedra, R, Zhao, H, Thieringer, R, Yamamoto, S, Fenton, M J, Golenbock, D T |
| author_sort | delude, r l |
| container_issue | 20 |
| container_start_page | 9288 |
| container_title | Proceedings of the National Academy of Sciences |
| container_volume | 92 |
| description | <jats:p>Binding of the lipid A portion of bacterial lipopolysaccharide (LPS) to leukocyte CD14 activates phagocytes and initiates the septic shock syndrome. Two lipid A analogs, lipid IVA and Rhodobacter sphaeroides lipid A (RSLA), have been described as LPS-receptor antagonists when tested with human phagocytes. In contrast, lipid IVA activated murine phagocytes, whereas RSLA was an LPS antagonist. Thus, these compounds displayed a species-specific pharmacology. To determine whether the species specificity of these LPS antagonists occurred as a result of interactions with CD14, the effects of lipid IVA and RSLA were examined by using human, mouse, and hamster cell lines transfected with murine or human CD14 cDNA expression vectors. These transfectants displayed sensitivities to lipid IVA and RSLA that reflected the sensitivities of macrophages of similar genotype (species) and were independent of the source of CD14 cDNA. For example, hamster macrophages and hamster fibroblasts transfected with either mouse or human-derived CD14 cDNA responded to lipid IVA and RSLA as LPS mimetics. Similarly, lipid IVA and RSLA acted as LPS antagonists in human phagocytes and human fibrosarcoma cells transfected with either mouse or human-derived CD14 cDNA. Therefore, the target of these LPS antagonists, which is encoded in the genomes of these cells, is distinct from CD14. Although the expression of CD14 is required for macrophage-like sensitivity to LPS, CD14 cannot discriminate between the lipid A moieties of these agents. We hypothesize that the target of the LPS antagonists is a lipid A recognition protein which functions as a signaling receptor that is triggered after interaction with CD14-bound LPS.</jats:p> |
| doi_str_mv | 10.1073/pnas.92.20.9288 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA3My9wbmFzLjkyLjIwLjkyODg |
| imprint | Proceedings of the National Academy of Sciences, 1995 |
| imprint_str_mv | Proceedings of the National Academy of Sciences, 1995 |
| institution | DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4 |
| issn | 0027-8424, 1091-6490 |
| issn_str_mv | 0027-8424, 1091-6490 |
| language | English |
| last_indexed | 2024-03-01T16:51:15.109Z |
| match_str | delude1995cd14enhancescellularresponsestoendotoxinwithoutimpartingligandspecificrecognition |
| mega_collection | Proceedings of the National Academy of Sciences (CrossRef) |
| physical | 9288-9292 |
| publishDate | 1995 |
| publishDateSort | 1995 |
| publisher | Proceedings of the National Academy of Sciences |
| record_format | ai |
| recordtype | ai |
| series | Proceedings of the National Academy of Sciences |
| source_id | 49 |
| spelling | Delude, R L Savedra, R Zhao, H Thieringer, R Yamamoto, S Fenton, M J Golenbock, D T 0027-8424 1091-6490 Proceedings of the National Academy of Sciences Multidisciplinary http://dx.doi.org/10.1073/pnas.92.20.9288 <jats:p>Binding of the lipid A portion of bacterial lipopolysaccharide (LPS) to leukocyte CD14 activates phagocytes and initiates the septic shock syndrome. Two lipid A analogs, lipid IVA and Rhodobacter sphaeroides lipid A (RSLA), have been described as LPS-receptor antagonists when tested with human phagocytes. In contrast, lipid IVA activated murine phagocytes, whereas RSLA was an LPS antagonist. Thus, these compounds displayed a species-specific pharmacology. To determine whether the species specificity of these LPS antagonists occurred as a result of interactions with CD14, the effects of lipid IVA and RSLA were examined by using human, mouse, and hamster cell lines transfected with murine or human CD14 cDNA expression vectors. These transfectants displayed sensitivities to lipid IVA and RSLA that reflected the sensitivities of macrophages of similar genotype (species) and were independent of the source of CD14 cDNA. For example, hamster macrophages and hamster fibroblasts transfected with either mouse or human-derived CD14 cDNA responded to lipid IVA and RSLA as LPS mimetics. Similarly, lipid IVA and RSLA acted as LPS antagonists in human phagocytes and human fibrosarcoma cells transfected with either mouse or human-derived CD14 cDNA. Therefore, the target of these LPS antagonists, which is encoded in the genomes of these cells, is distinct from CD14. Although the expression of CD14 is required for macrophage-like sensitivity to LPS, CD14 cannot discriminate between the lipid A moieties of these agents. We hypothesize that the target of the LPS antagonists is a lipid A recognition protein which functions as a signaling receptor that is triggered after interaction with CD14-bound LPS.</jats:p> CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proceedings of the National Academy of Sciences |
| spellingShingle | Delude, R L, Savedra, R, Zhao, H, Thieringer, R, Yamamoto, S, Fenton, M J, Golenbock, D T, Proceedings of the National Academy of Sciences, CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition., Multidisciplinary |
| title | CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_full | CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_fullStr | CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_full_unstemmed | CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_short | CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_sort | cd14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| title_unstemmed | CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. |
| topic | Multidisciplinary |
| url | http://dx.doi.org/10.1073/pnas.92.20.9288 |